
Abiomed
OrganizationHeard in 3 episodes across 1 show since Sep 2025
Abiomed develops mechanical circulatory-support devices, including the Impella heart pump platform, for patients with severe heart failure and during high-risk cardiac procedures. It is a Johnson & Johnson company.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 1 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 1 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
| Nov 2026 | 0 |
Email alert
Email me when Abiomed comes up on a podcast
One email a week at most, with the new episodes that mention Abiomed. Free, no account needed, unsubscribe in one click.
What experts have said about Abiomed
1 statement · 1 positive
Abiomed heart pumps extended ten-year survival by 600 days in studied patients.
“they were living over a 10-year period 600 days more.”
Open the episode · Mad Money w/ Jim Cramer 9/26/25Listen at 32:17
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Abiomed, newest first
- Jun 2, 2026
AI reshapes cybersecurity and the networks powering itMad Money w/ Jim CramerJun 2, 2026 - Jan 22, 2026
Cramer weighs J&J growth against 2026 market risksMad Money w/ Jim CramerJan 22, 2026 - Sep 26, 2025
Cramer tests the AI boom against company-by-company homeworkMad Money w/ Jim CramerSep 26, 2025